Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
Ion Beam Applications SA is a global leader in particle accelerator technology, specializing in the design, production, and marketing of innovative solutions for cancer diagnosis and treatment. Operating primarily through its Proton Therapy and Other Accelerators segment, the company develops medical and industrial particle accelerators, including proton therapy systems that deliver precise cancer treatments using proton beams, as well as cyclotrons for producing radioisotopes used in positron emission tomography and SPECT imaging. Its Dosimetry segment offers solutions to enhance efficiency and accuracy in radiation therapy and medical imaging quality assurance. Additional applications include industrial sterilization and ionization. Founded in 1986 and headquartered in Louvain-la-Neuve, Belgium, Ion Beam Applications SA employs around 2,000 people across more than 20 countries, including Belgium, the United States, Germany, and China. The company maintains strategic research partnerships, such as with SCK CEN for developing Actinium-225 isotopes, and innovations like ConformalFLASH technology. Certified as a B Corporation since 2021, it emphasizes sustainability through eco-design, renewable energy, and community initiatives, playing a pivotal role in advancing precision oncology and medical technology markets.